LAKE ELMO, Minn. and PITTSBURGH, March 13, 2017 -- Pathway Health has been selected by Curavi Health, a UPMC Enterprises-backed company, as its implementation, training and ongoing support services partner. Curavi Health will leverage Pathway Health’s vast network of more than 150 clinicians and technology experts to provide comprehensive implementation, training and ongoing support services for its telemedicine solutions aimed at helping nursing homes reduce potentially avoidable hospitalizations.
|
|||||
“We selected Pathway Health due its deep knowledge of the post-acute care continuum and expert consultants to provide seamless implementation and training of our novel telemedicine solution,” said Curavi Health President and Chief Executive Officer Nicholas J. Kuhn.
Curavi Health’s telemedicine solution includes CuraviCart™, a telemedicine cart specifically designed for the workflows associated with a nursing home, and CuraviCare™, a proprietary, HIPAA compliant video platform designed to easily facilitate interactions among a remote physician, the patient and nursing home staff.
“We look forward to supporting Curavi Health’s innovative telemedicine solution,” said Pathway Health Chief Executive Officer Peter B. Schuna. “As providers continue to implement strategies to improve patient outcomes while lowering costs, leveraging state-of-the-art technology will play an important role in providing quality, patient-centered care.”
About Curavi Health
Curavi, a Pittsburgh-based company, offers its customers CuraviCart telemedicine equipment, specifically designed for the workflow in the challenging, nursing-home environment, and CuraviCare software that allows staff to easily request a telemedicine consult. Curavi has also developed a formal relationship with University of Pittsburgh Physicians, part of UPMC, to provide after-hours consults from fellowship-trained geriatricians, as well as the Heart & Vascular Institute of UPMC to provide 1 hour turnaround on ECG reads. UPMC ranks No. 12 for geriatric medicine nationally in the latest quality scoring by U.S. News & World Report. For more information, call 1-888-5CURAVI or visit curavihealth.com.
About Pathway Health
Pathway Health is a professional management, consulting, interim management, executive search and education services organization, serving clients across the post-acute care continuum. Pathway Health holds the exclusive, global training license with Florida Atlantic University and provides high-quality training, education and consulting services to the post-acute providers using the Interventions to Reduce Acute Care Transfers (INTERACT™4.0) Quality Improvement Program (QIP). Since 1997, Pathway Health has been keeping a pulse on industry clinical, regulatory, quality and reimbursement trends to keep clients on the path to success. With over 150 experienced professionals, we engage and employ leading clinical and operational experts to assist our clients in achieving the next level of performance. For more information, call 877-777-5463 or visit pathwayhealth.com.
Media Contact for Pathway Health: Mopdog, Inc. Cheryl Musial Chief Strategy Officer [email protected] +1 678-737-7325 Media Contact for Curavi Health: University of Pittsburgh Medical Center (UPMC) Wendy Zellner Senior Director, Media Relations, UPMC [email protected] +1 412-586-9777


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 



